Ballicules.com

Ketamine

KETALAR

What it isNMDA receptor antagonist; anesthesia, procedural sedation, and off label for depression and chronic pain.

Why this oneIt relatively preserves airway reflexes and respiratory drive while supporting blood pressure, useful in shock or a difficult airway.

What limits itEmergence reactions, increased secretions and hypertension can end a trial. Abuse liability; Schedule III.

FDA-approved for

Off-label

FDA label

FDA dosingPopulationStartTargetMax
Induction of anesthesiaadult1-4.5 mg/kg IV slow (over 60 sec), or 1-2 mg/kg IV at 0.5 mg/kg/min
Induction of anesthesia (IM)adult6.5-13 mg/kg IM
Maintenance of anesthesiaadultone-half to full induction dose, repeat PRN

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Not recommended; animal data show possible fetal harm—avoid in pregnancy, labor, and delivery

Lactation Undefined

NO BOXED WARNINGS

Principal riskEmergence reactions; abuse liability

Cost, est. cash$20–$300/dose

Generic entryBy 2023

Classes and tags

Clinical profile

Therapeutic safety burden4 / 4
Overdose danger3 / 4
Weight-gain liability0 / 4
Sedation liability4 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityDissociation, sedation, blood-pressure and heart-rate elevation, emergence reactions and abuse/misuse potential; respiratory depression risk rises with other CNS depressants.

Mechanism of action: Ketamine ballicule

Ketamine ballicule: receptor binding, kinetics and half-life diagram

Open Ketamine in the interactive console ↗

Memory aids: mascots and interaction avatars

Ketamine KETALAR mascot mnemonic cartoon
“Cat taller (than) Cat tamer”
Ketamine CYP2B6 substrate avatar
CYP2B6 substrate

Open Ketamine in the interactive console ↗